HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lysophosphatidylserine has Bilateral Effects on Macrophages in the Pathogenesis of Atherosclerosis.

AbstractAIM:
Lysophospholipids, particularly sphingosine 1-phosphate and lysophosphatidic acid, are known to be involved in the pathogenesis of atherosclerosis; however, the role of lysophosphatidylserine (LysoPS) in the onset of atherosclerotic diseases remains uncertain.
METHODS:
We investigated the effects of LysoPS on the uptake of oxidized low-density lipoprotein (oxLDL) and the modulation of inflammatory mediators and ER stress utilizing RAW264.7 cells and mouse peritoneal macrophages (MPMs).
RESULTS:
We found that LysoPS augmented cholesterol accumulation in both models. Consistent with these findings, LysoPS increased the expression of scavenger receptors (CD36, MSR1, LOX1 and TLR4). Regarding the involvement of these lipids in inflammation, LysoPS significantly decreased the expression of inflammatory mediators in lipopolysaccharide (LPS)-treated RAW264.7 cells and MPMs. LysoPS also attenuated ER stress in LPS-untreated RAW264.7 cells. The expression patterns of LysoPS receptors differed considerably among the LPS-untreated RAW264.7 cells, LPS-treated RAW264.7 cells and MPMs.
CONCLUSIONS:
LysoPS may have proatherosclerotic properties in the setting of foam cell formation as well as antiatherosclerotic effects on inflammation in macrophages.
AuthorsMasako Nishikawa, Makoto Kurano, Hitoshi Ikeda, Junken Aoki, Yutaka Yatomi
JournalJournal of atherosclerosis and thrombosis (J Atheroscler Thromb) Vol. 22 Issue 5 Pg. 518-26 ( 2015) ISSN: 1880-3873 [Electronic] Japan
PMID25445889 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Lipopolysaccharides
  • Lipoproteins, LDL
  • Lysophospholipids
  • lysophosphatidylserine
  • oxidized low density lipoprotein
Topics
  • Animals
  • Atherosclerosis (physiopathology)
  • Cell Line
  • Endoplasmic Reticulum (metabolism)
  • Lipopolysaccharides (pharmacology)
  • Lipoproteins, LDL (metabolism)
  • Lysophospholipids (physiology)
  • Macrophages (drug effects, metabolism, physiology)
  • Mice

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: